1. Home
  2. KREF vs IVVD Comparison

KREF vs IVVD Comparison

Compare KREF & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KKR Real Estate Finance Trust Inc.

KREF

KKR Real Estate Finance Trust Inc.

HOLD

Current Price

$7.31

Market Cap

437.7M

Sector

Real Estate

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.74

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KREF
IVVD
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
437.7M
437.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KREF
IVVD
Price
$7.31
$1.74
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$9.80
$8.75
AVG Volume (30 Days)
1.3M
1.9M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
13.50%
N/A
EPS Growth
N/A
79.02
EPS
N/A
N/A
Revenue
N/A
$53,426,000.00
Revenue This Year
$560.38
$107.86
Revenue Next Year
$0.36
$146.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
110.47
52 Week Low
$6.64
$0.46
52 Week High
$11.53
$3.07

Technical Indicators

Market Signals
Indicator
KREF
IVVD
Relative Strength Index (RSI) 48.88 49.48
Support Level $6.64 $1.41
Resistance Level $9.43 $1.77
Average True Range (ATR) 0.22 0.10
MACD 0.09 0.04
Stochastic Oscillator 75.58 89.47

Price Performance

Historical Comparison
KREF
IVVD

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: